OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients
OPGEN INC (OPGN)
Last opgen inc earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.opgen.com
Company Research
Source: GlobeNewswire
- Investigator initiated study at Sweden’s Karolinska Institutet to test COVID-19 pneumonia patients with Unyvero HPN panel for bacterial co-infections - Rapid diagnostic tests are viewed as critical in this global outbreak response - Unyvero HPN panel for pneumonia to aid in early detection of hidden and life-threatening bacterial co-infections in COVID-19 patients GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, April 21, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to identify bacterial co-infections in patients admitted to the ICU for COVID-19 pneumonia using the Unyvero HPN panel. High-risk COVID-19 patients, especially in intensive care units and on ventilation, many of whom may be elderly or have preexisting conditions
Show less
Read more
Impact Snapshot
Event Time:
OPGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPGN alerts
High impacting OPGEN INC news events
Weekly update
A roundup of the hottest topics
OPGN
News
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
OPGN
Sec Filings
- 12/19/24 - Form 4
- 12/19/24 - Form 4
- 12/19/24 - Form 4
- OPGN's page on the SEC website